Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Duration: 48 months, Funding volume: € 899,099
The impact of mast cell activation on epithelial and endothelial barrier dysregulation in post-infectious ME/CFS
Duration: 12 months, Funding volume: € 99,992
Multiscale discovery of cellular and microanatomical determinants of metastasis
Duration: 48 months, Funding volume: € 799,960
Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Duration: 48 months, Funding volume: € 800,000
Decoding cellular senescence in glioblastoma (GlioAge)
Duration: 48 months, Funding volume: € 898,970
Lipid metabolism in granulomatous diseases
Duration: 18 months, Funding volume: € 74,930